• Company Information
  • About the Report
  • Documents
  • Outstanding Payments (MSME)
  • Complaints
  • Directors
  • Same Address Companies
  • Charges
  • Contact Details
  • Products & Services
  • Balance Sheet
  • Profit & Loss
  • Fund Raising
  • Shareholders & Investors
  • Board Meetings
  • Auditors

HAPAX PHARMA PRIVATE LIMITED

CIN: U24232GJ2014PTC080569 As on: 2026-07-13

HAPAX PHARMA PRIVATE LIMITED (CIN: U24232GJ2014PTC080569) is a Private company incorporated on 25 Aug 2014. It is classified as Non-government company and is registered at Registrar of Companies, Ahmedabad. Its authorized share capital is Rs. 1000000.00 and its paid up capital is Rs. 1000000.00.

HAPAX PHARMA PRIVATE LIMITED's Annual General Meeting (AGM) was last held on 30 Sep 2023. and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 2023-03-31.HAPAX PHARMA PRIVATE LIMITED's NIC code is 2423 (which is part of its CIN). As per the NIC code, it is inolved in Manufacture of pharmaceuticals, medicinal chemicals and botanical products.

Directors of HAPAX PHARMA PRIVATE LIMITED are SANJAYKUMAR JITENDRABHAI JHA, PRAKASH AMBALAL PATEL, KARTIK NALINBHAI RAVAL, and KALPESH NAVNITLAL SHAH.

HAPAX PHARMA PRIVATE LIMITED's Corporate Identification Number (CIN) is U24232GJ2014PTC080569 and its registration number is 80569. Users may contact HAPAX PHARMA PRIVATE LIMITED on its Email address - [email protected]. Registered address of HAPAX PHARMA PRIVATE LIMITED is SHOP NO. 413- 4TH FLR, SHANTI ARCADE, OPP. PUSHPAK APPT, NR. AKASH-3, 132 RING ROAD, NARANP URA, , AHMEDABAD, Gujarat, India - 380014.

Current status of HAPAX PHARMA PRIVATE LIMITED is - Active.

Basic Information

  • CIN
  • Name
  • Listed on Stock Exchange
  • Company Status
  • ROC
  • Registration Number
  • Company Category
  • Company Sub Category
  • Class of Company
  • Date of Incorporation
  • Age of Company
  • Activity
  • Number of Members

Annual Compliance Status

  • Date of Last Annual General Meeting
  • Date of Last Filed Balance Sheet

Key Numbers

  • Authorised Share Capital
  • Paid-up Share Capital
  • Total Assets
  • Revenue
  • Profit
  • Salaries & Other Employee Benefit Expenses
Want to see how this company compares within its industry or analyse broader market trends?
Explore Prime Research for Industry & Economic Insights

Previous Names

Previous CINs

ZaubaCorp's company report for HAPAX PHARMA includes audited balance sheets, profit & loss statements, charges, director history, shareholding and related-party transactions, compiled from official MCA filings — delivered as PDF and Excel.

Purchase Report

All companies in India are required to file various documents like financials, loan agreements, list of shareholders, details of directors, details of funding rounds and a lot more. These documents are credible and offer incredible insights about a company. However, understanding a company by viewing its documents is an extremely difficult and time consuming process.

Our reports are designed to save you significant time by surfacing key information easily and structuring it in a way that helps in your research.

Understanding the key findings and information in our reports can be crucial if you're a customer, vendor, investor, partner or even a potential employee of HAPAX PHARMA

Purchase full report of HAPAX PHARMA

Companies are required to file half yearly returns showing payments due to Micro & Small Enterprises that have been delayed more than 45 days. This information is crucial to understand if HAPAX PHARMA pays its vendors promptly. When seen over a period of time, this information could show if the company has slowed down in making payments to its small vendors. This information is available only if the company has filed its half yearly returns with the registrar of companies.

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay

This section contains details of investor complaints or serious complaints filed with the registrar of companies. This information can surface potential red flags about a company.

Director Complaints
Date DIN Cessation Date Cessation Reason Complaint
Serious Complaints
Date Complaint Other Details
Investor Complaints & Other Complaints
Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details

Current Directors & Key Managerial Personnel of HAPAX PHARMA
DIN Director Name Designation Appointment Date
01525404 SANJAYKUMAR JITENDRABHAI JHA Director 2014-08-25
02239510 PRAKASH AMBALAL PATEL Director 2019-09-30
02460674 KARTIK NALINBHAI RAVAL Director 2014-08-25
02727578 KALPESH NAVNITLAL SHAH Director 2019-09-30
Past Directors & Key Managerial Personnel of HAPAX PHARMA
DIN Director Name Designation Appointment Date Cessation
00385601 AMBALAL CHIMANLAL PATEL Director - 2019-02-02
01995701 DHRUMA JIGARBHAI SHAH Director - 2019-02-02
02239510 PRAKASH AMBALAL PATEL Additional Director - 2019-09-30
02727578 KALPESH NAVNITLAL SHAH Additional Director - 2019-09-30
Other Directorships of AMBALAL CHIMANLAL PATEL
Company Name CIN Designation Appointment Date Cessation
REIGN CREATORS LLP AAM-0699 Designated Partner 2018-02-21 Ongoing
SQUAREWATT DEVELOPERS LLP AAT-9538 Designated Partner - 2021-10-30
RATNABHUMI REALTY LLP AAV-0264 Partner 2022-06-30 Ongoing
SG MART LIMITED L46102DL1985PLC426661 Additional Director - 2015-08-22
SG MART LIMITED L46102DL1985PLC426661 Director - 2021-12-02
KESAR PHARMA PRIVATE LIMITED U24239GJ2011PTC067520 Director - 2019-09-06
KINTECH SYNERGY PRIVATE LIMITED U29120GJ1995PTC027101 Director 1996-05-07 Ongoing
RAJGARH WINDPARK PRIVATE LIMITED U31103TN2011PTC082117 Additional Director - 2013-09-13
RAJGARH WINDPARK PRIVATE LIMITED U31103TN2011PTC082117 Director - 2015-01-19
KINTECH SURAJBARI WINDPARK PRIVATE LIMITED U40100GJ2011PTC065587 Director 2011-05-24 Ongoing
KINTECH (GUJARAT) WINDPARK PRIVATE LIMITED U40100GJ2017PTC097522 Director 2017-05-23 Ongoing
SANTALPUR RENEWABLE POWER PRIVATE LIMITED U40102GJ2010PTC063242 Director - 2015-03-02
JANKI WINDFARM DEVELOPERS PRIVATE LIMITED U40106GJ2015PTC083076 Additional Director - 2016-05-11
JAINA WINDPARK PRIVATE LIMITED U40109GJ2012PTC070178 Director - 2014-03-28
KINTECH GLOBAL SERVICES PRIVATE LIMITED U40200GJ2016PTC091804 Director 2016-05-03 Ongoing
DIVINE WINDFARM PRIVATE LIMITED U40300GJ2012PTC073118 Director 2012-12-26 Ongoing
KINTECH (RAJASTHAN) WINDPARK PRIVATE LIMITED U40300GJ2017PTC097534 Director 2017-05-24 Ongoing
MANIHEM ENERFRA PRIVATE LIMITED U40300GJ2019PTC105966 Director 2019-01-09 Ongoing
KINTECH REALTY PRIVATE LIMITED U45201GJ2010PTC060002 Director - 2014-03-03
Other Directorships of SANJAYKUMAR JITENDRABHAI JHA
Company Name CIN Designation Appointment Date Cessation
SANTIS PHARMACEUTICALS PRIVATE LIMITED U24100GJ2010PTC060313 Director 2010-04-19 Ongoing
RATNATRIS PHARMACEUTICALS PRIVATE LIMITED U24230GJ2005PTC047394 Additional Director - 2019-09-30
RATNATRIS PHARMACEUTICALS PRIVATE LIMITED U24230GJ2005PTC047394 Director - 2021-07-10
CUIDADO MEDICO PRIVATE LIMITED U24230GJ2009PTC055921 Director 2009-01-20 Ongoing
NOSAK HEALTHCARE PRIVATE LIMITED U24230GJ2009PTC058623 Director 2009-11-18 Ongoing
AVENSIS PHARMACEUTICALS PRIVATE LIMITED U24230GJ2014PTC079251 Director 2014-03-20 Ongoing
SYNERGY PHARMASOURCE PRIVATE LIMITED U24239GJ2011PTC063969 Director 2011-02-09 Ongoing
SALVAVITA PHARMACEUTICALS PRIVATE LIMITED U24239GJ2020PTC119102 Director 2020-12-25 Ongoing
EVINOS PHARMACEUTICALS PRIVATE LIMITED U24290GJ2022PTC136805 Director - 2023-01-03
AVENSIS EXIM PRIVATE LIMITED U51109GJ2009PTC056485 Director 2009-03-31 Ongoing
EMZOR EXPORTS PRIVATE LIMITED U51909GJ2007PTC050786 Director 2007-05-11 Ongoing
SANTIS PETROCHEMICALS (OPC) PRIVATE LIMITED U51909GJ2016OPC094441 Director 2016-11-21 Ongoing
SUKARNOV PHARMACEUTICALS PRIVATE LIMITED U51909GJ2018PTC104568 Director 2018-10-04 Ongoing
PHARMACY NEXT DOOR PRIVATE LIMITED U51909GJ2019PTC109484 Director 2019-08-09 Ongoing
MIRAL PHARMACEUTICALS PRIVATE LIMITED U52100GJ2012PTC069616 Director 2012-03-28 Ongoing
ZORWAY EXIM PRIVATE LIMITED U52399GJ2010PTC059829 Director 2010-03-11 Ongoing
EXPERT SECOND OPINION SERVICES PRIVATE LIMITED U72900GJ2021PTC125908 Director 2021-09-28 Ongoing
ONNEXT HEALTHCARE PRIVATE LIMITED U74999GJ2017PTC096355 Director 2017-03-17 Ongoing
SANTIS HOSPITAL AND RESEARCH INSTITUTE PRIVATE LIMITED U85100GJ2021PTC122513 Director 2021-05-12 Ongoing
LOVE-SHREYA FILMS PRIVATE LIMITED U92490GJ2020PTC116608 Director 2020-09-17 Ongoing
Other Directorships of DHRUMA JIGARBHAI SHAH
Company Name CIN Designation Appointment Date Cessation
AETERNUS ENERGY LLP AAR-5943 Designated Partner 2020-01-13 Ongoing
KESAR PHARMA PRIVATE LIMITED U24239GJ2011PTC067520 Director - 2019-09-06
KINTECH SYNERGY PRIVATE LIMITED U29120GJ1995PTC027101 Director - 2014-03-01
JANKI WINDFARM DEVELOPERS PRIVATE LIMITED U40106GJ2015PTC083076 Additional Director - 2018-07-06
JANKI WINDFARM DEVELOPERS PRIVATE LIMITED U40106GJ2015PTC083076 Director 2018-07-06 Ongoing
KINTECH REALTY PRIVATE LIMITED U45201GJ2010PTC060002 Additional Director - 2014-09-30
KINTECH REALTY PRIVATE LIMITED U45201GJ2010PTC060002 Director 2014-09-30 Ongoing
Other Directorships of PRAKASH AMBALAL PATEL
Company Name CIN Designation Appointment Date Cessation
DHWANIT CONSULTANCY LLP ABZ-7294 Partner 2023-01-03 Ongoing
VEER ENERGY & INFRASTRUCTURE LIMITED L65990MH1980PLC023334 Director - 2013-03-16
KESAR FINECHEM PRIVATE LIMITED U24230GJ2021PTC127102 Additional Director - 2022-09-29
KESAR FINECHEM PRIVATE LIMITED U24230GJ2021PTC127102 Director 2022-09-05 Ongoing
KESAR PHARMA PRIVATE LIMITED U24239GJ2011PTC067520 Director 2011-10-18 Ongoing
JANKI WINDFARM DEVELOPERS PRIVATE LIMITED U40106GJ2015PTC083076 Additional Director - 2018-07-06
JANKI WINDFARM DEVELOPERS PRIVATE LIMITED U40106GJ2015PTC083076 Director 2018-07-06 Ongoing
KINTECH REALTY PRIVATE LIMITED U45201GJ2010PTC060002 Additional Director - 2014-09-30
KINTECH REALTY PRIVATE LIMITED U45201GJ2010PTC060002 Director 2014-09-30 Ongoing
KESAR CARE PRIVATE LIMITED U51109GJ2013PTC073213 Director 2013-01-02 Ongoing
DOVE RESOURCES PRIVATE LIMITED U74910GJ2008PTC054782 Additional Director - 2015-09-29
DOVE RESOURCES PRIVATE LIMITED U74910GJ2008PTC054782 Director 2015-09-29 Ongoing
DOVE RESOURCES PRIVATE LIMITED U74910GJ2008PTC054782 Director - 2011-05-30
Other Directorships of KARTIK NALINBHAI RAVAL
Company Name CIN Designation Appointment Date Cessation
CUIDADO MEDICO PRIVATE LIMITED U24230GJ2009PTC055921 Director 2009-01-20 Ongoing
SUKARNOV PHARMACEUTICALS PRIVATE LIMITED U51909GJ2018PTC104568 Director 2018-10-04 Ongoing
Other Directorships of KALPESH NAVNITLAL SHAH
Company Name CIN Designation Appointment Date Cessation
SELLWIN TRADERS LTD L51909WB1980PLC033018 Additional Director - 2023-09-28
SELLWIN TRADERS LTD L51909WB1980PLC033018 Director - 2023-10-06
KESAR FINECHEM PRIVATE LIMITED U24230GJ2021PTC127102 Additional Director - 2021-11-11
KESAR FINECHEM PRIVATE LIMITED U24230GJ2021PTC127102 Director 2021-11-11 Ongoing
AUROCARE LIFESCIENCES PRIVATE LIMITED U24233GJ2004PTC044672 Additional Director - 2012-09-01
KESAR PHARMA PRIVATE LIMITED U24239GJ2011PTC067520 Additional Director - 2014-09-29
KESAR PHARMA PRIVATE LIMITED U24239GJ2011PTC067520 Director 2014-09-29 Ongoing

CIN Company Name Company Address

Charge ID Charge Creation Date Charge Modification Date Charge Closure Date Assets Under Charge Amount Charge Holder

  • Email ID
  • Website
  • Address

This information shows products and services that contribute highest to the company's revenue. Analysing this over a period of time can show the evolution of the company in terms of the products and services it offers.

Financial Year Business Activity Code Business Activity Description Percentage of Turnover

Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.

2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31 2016-03-31 2015-03-31 2014-03-31 2013-03-31 2012-03-31
Download Audited Financials
EQUITY AND LIABILITIES
   Shareholder's funds
      Share Capital
      Reserves & Surplus
      Money Received Against Share Warrants
   Share Application Money Pending Allotment
   Non-current Liabilities
      Long-term borrowings
      Deferred tax liabilities
      Other Long Term Liabilities
      Long Term Provisions
   Current Liabilities
      Short-term borrowings
      Trade Payables
      Other Current Liabilities
      Short Term Provisions
Total Equity and Liabilities
ASSETS
   Non-current Assets
      Fixed Assets
         Tangible Assets
         Intangible Assets
         Capital Work In Progress
         Intangible Assets Under Development
      Non-current Investments
      Deferred Tax Assets (net)
      Long-term Loans & Advances
      Other Non-current Assets
   Current Assets
      Current Investments
      Inventories
      Trade receivables
      Cash & Cash Equivalents
      Short-term Loans & Advances
      Other Current Assets
Total Assets

Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.

2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31 2016-03-31 2015-03-31 2014-03-31 2013-03-31 2012-03-31
Download Audited Financials
REVENUE FROM OPERATIONS
   Domestic Turnover
      Sale of Goods Manufactured
      Sale of Goods Traded
      Sale of Supple of Services
   Export Turnover
      Sale of Goods Manufactured
      Sale of Goods Traded
      Sale or Supply of Services
   Other Income
Total Revenue From Operations
EXPENSES
   Cost of Materials Consumed
   Purchases of Stock in Trade
   Change in Inventories of
      Finished Goods
      Work in Progress
      Stock in Trade
   Employee benefit Expenses
   Managerial Remuneration
   Payment to Auditors
   Insurance Expenses
   Power & Fuel
   Finance Cost
   Depreciation & Amortization Expenses
   Other Expenses
Total Expenses
Profit before Exceptional Items, Extraordinary Items and Tax
   Exceptional Items
Profit before Extraordinary items and Tax
   Extraordinary Items
Profit before Tax
   Tax Expense
      Current Tax
      Deferred Tax
Profit/Loss after Tax from Continuing Operations
Profit/Loss after Tax from Discontinuing Operations
   Tax Expense of Discontinuing Operations
Total Profit/Loss
Earnings per Equity Share (EPS) before Extraordinary Items
   Basic
   Diluted
Earnings per Equity Share (EPS) after Extraordinary Items
   Basic
   Diluted

This section contains details of cash raised by allocation of equity or debentures. All types of fund raising acitivity is listed here including funding raised through Venture Capital. Attachments would contain further details of the fund raising activity including names of the investors. This information is available only if the company has raised funds through cash allotment of equity or debentures.

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments

This section contains list of associate companies and joint ventures as per the most recently available annual returns. This information would not be available if the company has not filed annual returns at all or it does not have any subsidiaries or joint ventures.

Company Identifier Name Percentage of Shares Held

This section contains list of board resolutions reported by the company to the Registrar of Companies.

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents

This section contains auditors of a company over the years. This information is available if the company has filed their annual returns with the Registrar of Companies.

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report

Is this information out of date or is there a discrepancy with the information? Click on the Update Information button below and we will review the information.

Purchase our hand crafted financial report for $ 9.99